Ultragenyx Pharmaceutical annual net debt
2019
2020
2021
2022
2023
2024
2025
Ultragenyx Pharmaceutical Net Debt Growth & History (RARE)
Ultragenyx Pharmaceutical's net debt was −$385.0M for fiscal 2025.
View full Ultragenyx Pharmaceutical company overviewUltragenyx Pharmaceutical annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$385.0M | −$251.3M | — |
| 2024 | 2024-12-31 | −$133.7M | $37.2M | — |
| 2023 | 2023-12-31 | −$170.8M | −$69.5M | — |
| 2022 | 2022-12-31 | −$101.4M | $164.3M | — |
| 2021 | 2021-12-31 | −$265.6M | $399.7M | — |
| 2020 | 2020-12-31 | −$665.3M | −$268.7M | — |
| 2019 | 2019-12-31 | −$396.6M | — | — |
Ultragenyx Pharmaceutical quarterly net debt
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$385.0M | −$251.3M | — |
| Q3 2025 | 2025-09-30 | −$168.7M | — | — |
| Q2 2025 | 2025-06-30 | −$139.7M | — | — |
| Q1 2025 | 2025-03-31 | −$88.7M | — | — |
| Q4 2024 | 2024-12-31 | −$133.7M | $37.2M | — |
| Q4 2023 | 2023-12-31 | −$170.8M | −$69.5M | — |
| Q4 2022 | 2022-12-31 | −$101.4M | $164.3M | — |
| Q4 2021 | 2021-12-31 | −$265.6M | $399.7M | — |
| Q4 2020 | 2020-12-31 | −$665.3M | −$268.7M | — |
| Q3 2020 | 2020-09-30 | −$153.0M | −$100.2M | — |
| Q2 2020 | 2020-06-30 | −$292.1M | −$233.7M | — |
| Q1 2020 | 2020-03-31 | −$255.7M | −$37.3M | — |
| Q4 2019 | 2019-12-31 | −$396.6M | — | — |
| Q3 2019 | 2019-09-30 | −$52.9M | — | — |
| Q2 2019 | 2019-06-30 | −$58.4M | — | — |
| Q1 2019 | 2019-03-31 | −$218.5M | — | — |
Ultragenyx Pharmaceutical net debt trends
Over the last five fiscal years, Ultragenyx Pharmaceutical's net debt increased from −$665.3M to −$385.0M, a change of $280.3M. The latest reported quarter, Q4 2025, shows −$385.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ultragenyx Pharmaceutical source filings ↗